144 related articles for article (PubMed ID: 30420405)
1. Identification of 19-(
Shoieb SM; El-Sherbeni AA; El-Kadi AOS
Drug Metab Dispos; 2019 Feb; 47(2):67-70. PubMed ID: 30420405
[TBL] [Abstract][Full Text] [Related]
2. Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1.
Shoieb SM; Dakarapu R; Falck JR; El-Kadi AOS
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):613-624. PubMed ID: 34235626
[TBL] [Abstract][Full Text] [Related]
3. 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners.
Isse FA; Alammari AH; El-Sherbeni AA; El-Kadi AOS
Prostaglandins Other Lipid Mediat; 2023 Oct; 168():106749. PubMed ID: 37244564
[TBL] [Abstract][Full Text] [Related]
4.
Shoieb SM; El-Kadi AOS
Drug Metab Dispos; 2018 Aug; 46(8):1157-1168. PubMed ID: 29880629
[TBL] [Abstract][Full Text] [Related]
5. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
Shoieb SM; El-Kadi AOS
Mol Cell Biochem; 2020 Aug; 471(1-2):165-176. PubMed ID: 32533462
[TBL] [Abstract][Full Text] [Related]
7. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
Maayah ZH; Althurwi HN; Abdelhamid G; Lesyk G; Jurasz P; El-Kadi AO
Pharmacol Res; 2016 Mar; 105():28-43. PubMed ID: 26772815
[TBL] [Abstract][Full Text] [Related]
8. 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism.
Hidayat R; Shoieb SM; Mosa FES; Barakat K; Brocks DR; Isse FA; Gerges SH; El-Kadi AOS
Mol Cell Biochem; 2023 Jul; ():. PubMed ID: 37436655
[TBL] [Abstract][Full Text] [Related]
9. 6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro.
Alammari AH; Gerges SH; Isse FA; El-Kadi AOS
Drug Metab Dispos; 2023 Jul; 51(7):833-843. PubMed ID: 37185150
[TBL] [Abstract][Full Text] [Related]
10. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.
Maayah ZH; El-Kadi AO
Arch Toxicol; 2016 Jan; 90(1):119-36. PubMed ID: 26525395
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene.
Chun YJ; Oh YK; Kim BJ; Kim D; Kim SS; Choi HK; Kim MY
Toxicol Lett; 2009 Aug; 189(1):84-9. PubMed ID: 19463925
[TBL] [Abstract][Full Text] [Related]
12. The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells.
Hidayat R; El-Ghiaty MA; Shoieb SM; Alqahtani MA; El-Kadi AOS
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):709-722. PubMed ID: 37815672
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin.
Zhang Y; Wang S; Huang Y; Yang K; Liu Y; Bi X; Liu C; Xiong J; Zhang B; Zhao J; Nie L
Mol Med Rep; 2020 Jan; 21(1):393-404. PubMed ID: 31746392
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors.
Dong J; Wang Z; Cui J; Meng Q; Li S
Eur J Med Chem; 2020 Feb; 187():111938. PubMed ID: 31830634
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis, structure and biological activity of hydroxyeicosatetraenoic acids in Hydra vulgaris.
Di Marzo V; De Petrocellis L; Gianfrani C; Cimino G
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):23-9. PubMed ID: 8216222
[TBL] [Abstract][Full Text] [Related]
16. Sex- and enantiospecific differences in the formation rate of hydroxyeicosatetraenoic acids in rat organs.
Gerges SH; Alammari AH; El-Ghiaty MA; Isse FA; El-Kadi AOS
Can J Physiol Pharmacol; 2023 Aug; 101(8):425-436. PubMed ID: 37220651
[TBL] [Abstract][Full Text] [Related]
17. 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.
Elkhatali S; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; El-Kadi AO
Toxicol Appl Pharmacol; 2015 Dec; 289(3):550-9. PubMed ID: 26454030
[TBL] [Abstract][Full Text] [Related]
18. Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
Alammari AH; Shoieb SM; Maayah ZH; El-Kadi AOS
J Pharm Sci; 2020 Jul; 109(7):2321-2335. PubMed ID: 32240690
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides.
Carroll MA; Balazy M; Margiotta P; Huang DD; Falck JR; McGiff JC
Am J Physiol; 1996 Oct; 271(4 Pt 2):R863-9. PubMed ID: 8897975
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy.
Elkhatali S; Maayah ZH; El-Sherbeni AA; Elshenawy OH; Abdelhamid G; Shoieb SM; El-Kadi AOS
J Cardiovasc Pharmacol; 2017 Jul; 70(1):16-24. PubMed ID: 28437282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
